Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 3/2012

Content (20 Articles)

editorial

ASH 2011: “Real generosity toward the future lies in giving all to the present”

Michael Steurer

editorial

News from the Neuro-Oncology front

Silvia Hofer, Christine Marosi

special report

ASH 2011—Hodgkin’s disease and the high grade lymphomas

Wolfgang Willenbacher, Ella Willenbacher

short review

Treating T-cell lymphoma: is there a light at the end of the tunnel?

Georg Hopfinger, Olaf Merkel, Thomas Melchardt, Richard Greil

short review

ASH update 2011: chronic lymphocytic leukemia and indolent lymphoma

Michael Steurer

short review

Brief update on recent developments in CML

Stefan Schmidt

short review

New developments in MDS

Michael Pfeilstöcker, Reinhard Stauder

short review

ASH 2011—current developments in AML

Johannes Clausen

short review

Primary central nervous system lymphoma: update and current approach

Lauren E. Abrey

short review

Paraneoplastic neurologic disorders: a brief overview

Myrna R. Rosenfeld, Josep Dalmau

short review

Clinically useful biomarkers in neurooncology

Matthias Preusser

short review

Carcinomatous meningitis

Marc C. Chamberlain

short review

Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology

Bernhard Schuknecht, Krisztina Baráth, Silvia Hofer

short review

Drug therapy for recurrent, progressive, atypical, and malignant meningiomas

Christine Marosi

Open Access review

Current treatment of low grade gliomas

Martin J. van den Bent, Tom J. Snijders, Jacoline E. C. Bromberg

Open Access short review

Update on molecular and genetic alterations in adult medulloblastoma

Marcel Kool, Andrey Korshunov, Stefan M. Pfister

short review

The End-of-Life in patients with glioma and their families

Christine Marosi, Birgit Flechl, Stefan Oberndorfer

short review

New drugs for head and neck cancer

József Dudás, Heinz Zwierzina, Georg Mathias Sprinzl

short review

Follow-up care for head and neck cancer patients

Markus Hambek

case report

Sorafenib in thyroid cancer—a retrospective case series

Gabriele Gamerith, Andreas Pircher, Arno Amann, Katharina Cima, Klaus Gasser, Markus Lenzhofer, Peter Lind, Evelyne Bareck, Ewald Wöll, Wolfgang Hilbe

Jun 12
Issue: 2/2012
Dec 12
Issue: 4/2012

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits